In a report released yesterday, Uy Ear from Mizuho Securities reiterated a Buy rating on Cabaletta Bio (CABA - Research Report), with a price target of $10.00. The company's shares closed yesterday at $1.45.According to TipRanks, Ear is a 4-star analyst with an average return of 15.5% and a 66.67% success rate. Ear covers the Healthcare sector, focusing on stocks such as Arcutis Biotherapeutics, ACADIA Pharmaceuticals, and uniQure.Currently, the analyst consensus on Cabaletta Bio is a Moderate Buy with an average price target of $10.50.
https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-its-buy-rating-for-cabaletta-bio-caba-2?utm_source=advfn.com&utm_medium=referral